BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28184936)

  • 1. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
    Xu H; Qian M; Zhao B; Wu C; Maskey N; Song H; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2017 Mar; 37(3):1619-1626. PubMed ID: 28184936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
    Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
    Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
    Li Z; Li Y; Jia Y; Ding B; Yu J
    Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
    Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
    Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑139‑3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A.
    Zhang W; Xu J; Wang K; Tang X; He J
    Oncol Rep; 2019 Nov; 42(5):1699-1708. PubMed ID: 31485677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAB1A regulates glioma cellular proliferation and invasion via the mTOR signaling pathway and epithelial-mesenchymal transition.
    Ren B; Wang L; Nan Y; Liu T; Zhao L; Ma H; Li J; Zhang Y; Ren X
    Future Oncol; 2021 Aug; 17(24):3203-3216. PubMed ID: 33947216
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.
    Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z
    Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
    Zhang P; Yang X; Yin Q; Yi J; Shen W; Zhao L; Zhu Z; Liu J
    PLoS One; 2016; 11(4):e0154471. PubMed ID: 27124117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells.
    Amith SR; Wilkinson JM; Fliegel L
    Oncotarget; 2016 Apr; 7(16):21091-113. PubMed ID: 27049728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
    Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
    Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
    Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
    Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.